Home/Filings/4/0001140361-17-020114
4//SEC Filing

CESCA THERAPEUTICS INC. 4

Accession 0001140361-17-020114

$THMOCIK 0000811212operating

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:30 PM ET

Size

7.0 KB

Accession

0001140361-17-020114

Insider Transaction Report

Form 4
Period: 2017-05-10
Transactions
  • Award

    Stock Options

    2017-05-10$3.19/sh+12,250$39,07812,250 total
    Exercise: $3.19Exp: 2027-05-10Common Stock (12,250 underlying)
Holdings
  • Stock Options

    Exercise: $2.89Exp: 2024-02-24Common Stock (1,250 underlying)
    1,250
Footnotes (2)
  • [F1]The option vests as to 2,040 shares on the date of grant, 510 shares on the last day of each month thereafter for 19 months (beginning on June 30, 2017) and 520 shares on January 31, 2019, subject to the early termination provisions and other terms and conditions of the 2016 Equity Incentive Plan, as amended.
  • [F2]Options vest monthly over a one year period. Under the terms of the award agreement, no portion of the options may be exercised and no stock underlying the option will be issued under our 2016 Equity Incentive Plan until our stockholders approve such plan.

Documents

1 file

Issuer

CESCA THERAPEUTICS INC.

CIK 0000811212

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000811212

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:30 PM ET
Size
7.0 KB